An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
<iframe src="https://statesidedaily.com/embed/cluster/e7ecf8fcff1ca7888f7dc9eaeabaf114f519d564" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="What would it take to get peptides on the shelf?"></iframe>
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
